‘Hidden champions,’ Japanese pharmas to target Korean market

Published: 2016-10-31 14:09:19

Updated: 2016-10-31 14:09:29

Japanese pharmaceutical companies branched in Korea are on a roll, showing themselves as ‘hidden champions’ in the Korean industry. Although they are not as global as international companies such as Novartis and Pfizer, they seem to effectively target the blue ocean market with tailored strategies.

According to the analysis result of this 3^rd quarter’s outpatient prescription records of Japan...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.